AGWCA
TMDX icon

Annis Gardner Whiting Capital Advisors’s Transmedics TMDX Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,637
Closed -$262K – 1160
2026
Q1 		$262K Buy
2,637
+1
+0% +$130 0.04% 275
2025
Q4 		$321K Buy
2,636
+1,090
+71% +$137K 0.06% 237
2025
Q3 		$173K Buy
1,546
+1,516
+5,053% +$177K 0.04% 285
2025
Q2 		$4.02K Buy
+30
New +$3.29K ﹤0.01% 885

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Asset Management International
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hood River Capital Management
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's TMDX Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 2,637 shares — an estimated $262K sold.

Annis Gardner Whiting Capital Advisors first reported a position in TMDX in Q2 2025 and held it in 4 quarters. The position peaked at $321K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 2,637 Transmedics shares in Q2 2026, an estimated $262K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Transmedics in Q2 2025 and held it in 4 quarters.
  • Annis Gardner Whiting Capital Advisors's Transmedics position peaked at $321K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.